Exploiting mucosal surfaces for the development of mucosal vaccines

Vaccine

Volumn 29, Issue 47, 2011, Pages 8506-8511

  Meeusen, Els N ^a,b  

^a MONASH UNIVERSITY   (Australia)

^b Australian Government Australian Research Council   (Australia)

Author keywords

Lymphocyte migration; Mucosal adjuvants; Mucosal vaccines; Tissue specific immunity

Indexed keywords

ADJUVANT; ANTIGEN; CHOLERA VACCINE; IMMUNOGLOBULIN A; VACCINE;

B LYMPHOCYTE; CELL DIFFERENTIATION; DRUG DESIGN; HUMAN; IMMUNE RESPONSE; IMMUNIZATION; IMMUNOGLOBULIN PRODUCTION; LYMPH NODE; LYMPHOCYTE MIGRATION; MICROENVIRONMENT; MUCOSAL IMMUNITY; NONHUMAN; PRIORITY JOURNAL; REVIEW; TISSUE SPECIFICITY; VACCINATION;

ADMINISTRATION, MUCOSAL; ANIMALS; HUMANS; IMMUNITY, MUCOSAL; IMMUNIZATION; VACCINES;

EID: 82455175404     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2011.09.010     Document Type: Review

References (69)

1. Cerutti A. The regulation of IgA class switching. Nat Rev Immunol 2008, 8(June (6)):421-434.
2. McGuckin M.A., Linden S.K., Sutton P., Florin T.H. Mucin dynamics and enteric pathogens. Nat Rev Microbiol 2011, 9(April (4)):265-278.
3. Strugnell R.A., Wijburg O.L. The role of secretory antibodies in infection immunity. Nat Rev Microbiol 2010, 8(September (9)):656-667.
4. Forrest B.D. Identification of an intestinal immune response using peripheral blood lymphocytes. Lancet 1988, 1(January (8577)):81-83.
5. Macpherson A.J., McCoy K.D., Johansen F.E., Brandtzaeg P. The immune geography of IgA induction and function. Mucosal Immunol 2008, 1(January (1)):11-22.
6. Premier R.R., Jacobs H.J., Lofthouse S.A., Sedgmen B.J., Meeusen E.N. Antibody isotype profiles in serum and circulating antibody-secreting cells following mucosal and peripheral immunisations of sheep. Vet Immunol Immunopathol 2004, 98(March (1-2)):77-84.
7. Brandtzaeg P. Regionalized immune function of tonsils and adenoids. Immunol Today 1999, 20(August (8)):383-384.
8. Czerkinsky C.C., Nilsson L.A., Nygren H., Ouchterlony O., Tarkowski A. A solid-phase enzyme-linked immunospot (ELISPOT) assay for enumeration of specific antibody-secreting cells. J Immunol Methods 1983, 65(December (1-2)):109-121.
9. Nieminen T., Kayhty H., Virolainen A., Eskola J. Circulating antibody secreting cell response to parenteral pneumococcal vaccines as an indicator of a salivary IgA antibody response. Vaccine 1998, 16(January-February (2-3)):313-319.
10. Pasetti M.F., Simon J.K., Sztein M.B., Levine M.M. Immunology of gut mucosal vaccines. Immunol Rev 2011, 239(January (1)):125-148.
11. Quiding-Jarbrink M., Nordstrom I., Granstrom G., Kilander A., Jertborn M., Butcher E.C., et al. Differential expression of tissue-specific adhesion molecules on human circulating antibody-forming cells after systemic, enteric, and nasal immunizations. A molecular basis for the compartmentalization of effector B cell responses. J Clin Invest 1997, 99(March (6)):1281-1286.
12. Sedgmen B.J., Lofthouse S.A., Meeusen E.N. Optimization of an ovine antibody-secreting cell assay for detection of antigen-specific immunoglobulin production in peripheral blood leukocytes. Immunol Cell Biol 2003, 81(August (4)):305-310.
13. de Veer M.J., Kemp J.M., Meeusen E.N. The innate host defence against nematode parasites. Parasite Immunol 2007, 29(January (1)):1-9.
14. Dunphy J.L., Balic A., Barcham G.J., Horvath A.J., Nash A.D., Meeusen E.N. Isolation and characterization of a novel inducible mammalian galectin. J Biol Chem 2000, 275(October (41)):32106-32113.
15. Iwasaki A. Antiviral immune responses in the genital tract: clues for vaccines. Nat Rev Immunol 2010, 10(October (10)):699-711.
16. Hussain L.A., Lehner T. Comparative investigation of Langerhans' cells and potential receptors for HIV in oral, genitourinary and rectal epithelia. Immunology 1995, 85(July (3)):475-484.
17. Holt P.G., Strickland D.H., Wikstrom M.E., Jahnsen F.L. Regulation of immunological homeostasis in the respiratory tract. Nat Rev Immunol 2008, 8(February (2)):142-152.
18. Tschernig T., Pabst R. What is the clinical relevance of different lung compartments?. BMC Pulm Med 2009, 9:39.
19. Sou T., Meeusen E.N., de Veer M., Morton D.A., Kaminskas L.M., McIntosh M.P. New developments in dry powder pulmonary vaccine delivery. Trends Biotechnol 2011, 29(April (4)):191-198.
20. Allen J.E., Bischof R.J., Sucie Chang H.Y., Hirota J.A., Hirst S.J., Inman M.D., et al. Animal models of airway inflammation and airway smooth muscle remodelling in asthma. Pulm Pharmacol Ther 2009, 22(October (5)):455-465.
21. Meeusen E.N., Snibson K.J., Hirst S.J., Bischof R.J. Sheep as a model species for the study and treatment of human asthma and other respiratory diseases. Drug Discov Today: Dis Models 2009, 6(4):101-106.
22. Chen K., Cerutti A. Vaccination strategies to promote mucosal antibody responses. Immunity 2010, 33(October (4)):479-491.
23. Czerkinsky C., Holmgren J. Topical immunization strategies. Mucosal Immunol 2010, 3(November (6)):545-555.
24. Brandtzaeg P. Mucosal immunity: induction, dissemination, and effector functions. Scand J Immunol 2009, 70(December (6)):505-515.
25. Liebler-Tenorio E.M., Pabst R. MALT structure and function in farm animals. Vet Res 2006, 37(May-June (3)):257-280.
26. Balic A., Bowles V.M., Meeusen E.N. The immunobiology of gastrointestinal nematode infections in ruminants. Adv Parasitol 2000, 45:181-241.
27. Cerf-Bensussan N., Gaboriau-Routhiau V. The immune system and the gut microbiota: friends or foes?. Nat Rev Immunol 2010, 10(October (10)):735-744.
28. Mestecky J. The common mucosal immune system and current strategies for induction of immune responses in external secretions. J Clin Immunol 1987, 7(July (4)):265-276.
29. Gill N., Wlodarska M., Finlay B.B. The future of mucosal immunology: studying an integrated system-wide organ. Nat Immunol 2010, 11(July (7)):558-560.
30. Meeusen E.N., Premier R.R., Brandon M.R. Tissue-specific migration of lymphocytes: a key role for Th1 and Th2 cells?. Immunol Today 1996, 17(September (9)):421-424.
31. Cyster J.G. Homing of antibody secreting cells. Immunol Rev 2003, 194(August):48-60.
32. Premier R.R., Meeusen E.N. Lymphocyte surface marker and cytokine expression in peripheral and mucosal lymph nodes. Immunology 1998, 94(July (3)):363-367.
33. Iwata M., Hirakiyama A., Eshima Y., Kagechika H., Kato C., Song S.Y. Retinoic acid imprints gut-homing specificity on T cells. Immunity 2004, 21(October (4)):527-538.
34. Mora J.R., Iwata M., Eksteen B., Song S.Y., Junt T., Senman B., et al. Generation of gut-homing IgA-secreting B cells by intestinal dendritic cells. Science 2006, 314(November (5802)):1157-1160.
35. Premier R.R., Jacobs H.J., Brandon M.R., Meeusen E.N. Distribution of antigen specific memory T cells in lymph nodes after immunization at peripheral or mucosal sites. Immunol Cell Biol 1996, 74(June (3)):265-273.
36. Meeusen E.N., Balic A. Do eosinophils have a role in the killing of helminth parasites?. Parasitol Today 2000, 16(March (3)):95-101.
37. Matzinger P., Kamala T. Tissue-based class control: the other side of tolerance. Nat Rev Immunol 2011, 11(March (3)):221-230.
38. Picker L.J. Mechanisms of lymphocyte homing. Curr Opin Immunol 1992, 4(June (3)):277-286.
39. Meeusen E.N. Differential migration of Th1 and Th2 cells-implications for vaccine and infection studies. Vet Immunol Immunopathol 1998, 63(May (1-2)):157-166.
40. Meeusen E., Brandon M. The use of antibody-secreting cell probes to reveal tissue-restricted immune responses during infection. Eur J Immunol 1994, 24(February (2)):469-474.
41. Constant S.L., Brogdon J.L., Piggott D.A., Herrick C.A., Visintin I., Ruddle N.H., et al. Resident lung antigen-presenting cells have the capacity to promote Th2 T cell differentiation in situ. J Clin Invest 2002, 110(November (10)):1441-1448.
42. Lawson L.B., Norton E.B., Clements J.D. Defending the mucosa: adjuvant and carrier formulations for mucosal immunity. Curr Opin Immunol 2011, 23(April (3)):414-420.
43. Baudner B.C., O'Hagan D.T. Bioadhesive delivery systems for mucosal vaccine delivery. J Drug Target 2010, 18(December (10)):752-770.
44. Yamamoto S., Takeda Y., Yamamoto M., Kurazono H., Imaoka K., Fujihashi K., et al. Mutants in the ADP-ribosyltransferase cleft of cholera toxin lack diarrheagenicity but retain adjuvanticity. J Exp Med 1997, 185(April (7)):1203-1210.
45. Glenn G.M., Rao M., Matyas G.R., Alving C.R. Skin immunization made possible by cholera toxin. Nature 1998, 391(February (6670)):851.
46. Meeusen E.N., Scheerlinck J.P., Wattegedera S., Entrican G. Advances in mucosal vaccination. Anim Health Res Rev 2004, 5(December (2)):209-217.
47. Ahrendt M., Hammerschmidt S.I., Pabst O., Pabst R., Bode U. Stromal cells confer lymph node-specific properties by shaping a unique microenvironment influencing local immune responses. J Immunol 2008, 181(August (3)):1898-1907.
48. Hammerschmidt S.I., Ahrendt M., Bode U., Wahl B., Kremmer E., Forster R., et al. Stromal mesenteric lymph node cells are essential for the generation of gut-homing T cells in vivo. J Exp Med 2008, 205(October (11)):2483-2490.
49. Mueller S.N., Germain R.N. Stromal cell contributions to the homeostasis and functionality of the immune system. Nat Rev Immunol 2009, 9(September (9)):618-629.
50. Everson M.P., McDuffie D.S., Lemak D.G., Koopman W.J., McGhee J.R., Beagley K.W. Dendritic cells from different tissues induce production of different T cell cytokine profiles. J Leukoc Biol 1996, 59(April (4)):494-498.
51. Meeusen E.N., Walker J., Peters A., Pastoret P.P., Jungersen G. Current status of veterinary vaccines. Clin Microbiol Rev 2007, 20(July (3)):489-510.
52. Mishra N., Goyal A.K., Tiwari S., Paliwal R., Paliwal S.R., Vaidya B., et al. Recent advances in mucosal delivery of vaccines: role of mucoadhesive/biodegradable polymeric carriers. Expert Opin Ther Pat 2010, 20(May (5)):661-679.
53. Wiedermann U., Kollaritsch H. Vaccines against traveler's diarrhoea and rotavirus disease - a review. Wien Klin Wochenschr 2006, 118(19-20 Suppl. 3):2-8.
54. Alpar H.O., Eyles J.E., Williamson E.D., Somavarapu S. Intranasal vaccination against plague, tetanus and diphtheria. Adv Drug Deliv Rev 2001, 51(September (1-3)):173-201.
55. Heegaard P.M., Dedieu L., Johnson N., Le Potier M.F., Mockey M., Mutinelli F., et al. Adjuvants and delivery systems in veterinary vaccinology: current state and future developments. Arch Virol 2011, 156(February (2)):183-202.
56. Kweon M.N. Sublingual mucosa: a new vaccination route for systemic and mucosal immunity. Cytokine 2011, 54(April (1)):1-5.
57. Ayalew S., Step D.L., Montelongo M., Confer A.W. Intranasal vaccination of calves with Mannheimia haemolytica chimeric protein containing the major surface epitope of outer membrane lipoprotein PlpE, the neutralizing epitope of leukotoxin, and cholera toxin subunit B. Vet Immunol Immunopathol 2009, 132(December (2-4)):295-302.
58. Sedgmen B.J., Lofthouse S.A., Meeusen E.N. The ovine nasal mucosa: an alternative tissue site for mucosal immunization. Methods 2006, 38(February (2)):112-116.
59. Jacobs H.J., Wiltshire C., Ashman K., Meeusen E.N. Vaccination against the gastrointestinal nematode, Haemonchus contortus, using a purified larval surface antigen. Vaccine 1999, 17(January (4)):362-368.
60. Duthie M.S., Windish H.P., Fox C.B., Reed S.G. Use of defined TLR ligands as adjuvants within human vaccines. Immunol Rev 2011, 239(January (1)):178-196.
61. Enioutina E.Y., Visic D., Daynes R.A. The induction of systemic and mucosal immune responses to antigen-adjuvant compositions administered into the skin: alterations in the migratory properties of dendritic cells appears to be important for stimulating mucosal immunity. Vaccine 2000, 18(June (24)):2753-2767.
62. Liard C., Munier S., Arias M., Joulin-Giet A., Bonduelle O., Duffy D., et al. Targeting of HIV-p24 particle-based vaccine into differential skin layers induces distinct arms of the immune responses. Vaccine 2011, 29(May (37)):6279-6391.
63. Skountzou I., Quan F.S., Jacob J., Compans R.W., Kang S.M. Transcutaneous immunization with inactivated influenza virus induces protective immune responses. Vaccine 2006, 24(August (35-36)):6110-6119.
64. Hammerschmidt S.I., Friedrichsen M., Boelter J., Lyszkiewicz M., Kremmer E., Pabst O., et al. Retinoic acid induces homing of protective T and B cells to the gut after subcutaneous immunization in mice. J Clin Invest 2011, 121(July (8)):3051-3061.
65. Herremans T.M., Reimerink J.H., Buisman A.M., Kimman T.G., Koopmans M.P. Induction of mucosal immunity by inactivated poliovirus vaccine is dependent on previous mucosal contact with live virus. J Immunol 1999, 162(April (8)):5011-5018.
66. de Veer M., Kemp J., Chatelier J., Elhay M.J., Meeusen E.N.T. The kinetics of soluble and particulate antigen trafficking in the afferent lymph, and its modulation by aluminum-based adjuvant. Vaccine 2010, 28(40):6597-6602.
67. Schwartz-Cornil I., Epardaud M., Bonneau M. Cervical duct cannulation in sheep for collection of afferent lymph dendritic cells from head tissues. Nat Protoc 2006, 1(2):874-879.
68. Yen H.H., Wee J.L., Snibson K.J., Scheerlinck J.P. Thoracic duct cannulation without thoracotomy in sheep: a method for accessing efferent lymph from the lung. Vet Immunol Immunopathol 2009, 129(May (1-2)):76-81.
69. Hapfelmeier S., Lawson M.A., Slack E., Kirundi J.K., Stoel M., Heikenwalder M., et al. Reversible microbial colonization of germ-free mice reveals the dynamics of IgA immune responses. Science 2010, 328(June (5986)):1705-1709.